In our research, low expression of AR (6.5%) was observed, in contrast to the literature, in which the values for grade I meningiomas range from 31.0 to 40.3% (11, 13, 92), and in all grades from 18.3 to 67% (82, 86, 93) (Table 10). This evidence concerns the gene AR and meningioma.